English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17939/22958 (78%)
Visitors : 7384284      Online Users : 148
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Category

    Loading community tree, please wait....

    Year

    Loading year class tree, please wait....

    Items for Author "Deodhar, A" 

    Return to Browse by Author

    Showing 6 items.

    Collection Date Title Authors Bitstream
    [中山醫學大學研究成果] 其他文獻 2020 ETANERCEPT WITHDRAWAL AND RE-TREATMENT IN PATIENTS WITH INACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AT 24 WEEKS: RESULTS OF RE-EMBARK, AN OPEN-LABEL, PHASE IV TRIAL Van den Bosch, F; Wei, JCC; Nash, P; Blanco, FJ; Graham, D; Zang, C; Arthur, E; Borlenghi, C; Vlahos, B; Deodhar, A
    [中山醫學大學研究成果] 其他文獻 2020 Predictors of Maintaining Inactive Disease After Etanercept Withdrawal, and Regaining Inactive Disease Status After Flare and Retreatment, in Adults with Non-radiographic Axial Spondyloarthritis: Results from RE-EMBARK Van den Bosch, F; Wei, JCC; Blanco, F; Selema, P; Graham, D; Arthur, E; Tsekouras, V; Vlahos, B; Zang, CB; Deodhar, A; Nash, P
    [中山醫學大學研究成果] 其他文獻 2020 Efficacy Outcomes Following Etanercept Withdrawal by Sustained Remission Status in Patients with Nr-axSpA: Results from RE-EMBARK van den Bosch, F; Nash, P; Wei, JCC; Blanco, F; Tsekouras, V; Zang, CB; Graham, D; Arthur, E; Selema, P; Vlahos, B; Deodhar, A
    [中山醫學大學研究成果] 期刊論文 2020 Secukinumab Demonstrates Sustained Efficacy and Safety in a Taiwanese Subpopulation With Active Ankylosing Spondylitis: Four-Year Results From a Phase 3 Study, MEASURE 1 Tseng, JC; Wei, JCC; Deodhar, A; Martin, R; Porter, B; McCreddin, S; Talloczy, Z
    [中山醫學大學研究成果] 期刊論文 2020 Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks Marzo-Ortega, H; Mease, PJ; Rahman, P; Navarro-Compan, V; Strand, V; Dougados, M; Combe, B; Wei, JCC; Baraliakos, X; Hunter, T; Sandoval, D; Li, XQ; Zhu, BJ; Bessette, L; Deodhar, A
    [中山醫學大學研究成果] 期刊論文 2020 Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W) Dougados, M; Wei, JCC; Landewe, R; Sieper, J; Baraliakos, X; Van den Bosch, F; Maksymowych, WP; Ermann, J; Walsh, JA; Tomita, T; Deodhar, A; van der Heijde, D; Li, XQ; Zhao, FY; Bertram, CC; Gallo, G; Carlier, H; Gensler, LS

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback